MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income and other
income (expense), net
$520K
Net loss
-$26,262K
Other income
(expense), net
$313K
Interest expense
$207K
Operating loss
-$26,575K
General and
administrative
$13,969K
Research and development
$12,606K
Back
Back
Income Statement
source: myfinsight.com
Tempest Therapeutics, Inc. (TPST)
Tempest Therapeutics, Inc. (TPST)